Early research (Phase 1)Active Not RecruitingNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Testing effectiveness (Phase 2)WithdrawnNCT02535078What this trial is testingPhase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous MelanomaWho this might be right forMalignant Melanoma Immunocore Ltd
Testing effectiveness (Phase 2)Ended earlyNCT02978443What this trial is testingA Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With IpilimumabWho this might be right forAcral Lentiginous MelanomaMucosal Melanoma Georgetown University 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT03698019What this trial is testingCompare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk MelanomaWho this might be right forAcral Lentiginous MelanomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+1 more National Cancer Institute (NCI) 313
Early research (Phase 1)Looking for participantsNCT04119024What this trial is testingGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more Anusha Kalbasi 18
Testing effectiveness (Phase 2)Ended earlyNCT01092728What this trial is testingTreatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged MelanomaWho this might be right forMelanoma M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT07155317What this trial is testingTime-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME TrialWho this might be right forAdvanced Acral MelanomaAdvanced Cutaneous MelanomaAdvanced Mucosal Melanoma+7 more Emory University 99
Early research (Phase 1)Ended earlyNCT02346955What this trial is testingStudy of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)Who this might be right forNon-small Cell Lung Carcinoma (NSCLC)MelanomaBladder Cancer+3 more Famewave Ltd. 27
Testing effectiveness (Phase 2)Study completedNCT01395121What this trial is testingA Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has SpreadWho this might be right forMucosal Lentiginous MelanomaAcral Lentiginous Malignant Melanoma Institute of Cancer Research, United Kingdom 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT00937937What this trial is testingDinaciclib in Treating Patients With Stage IV MelanomaWho this might be right forAcral Lentiginous MelanomaCutaneous Nodular MelanomaLentigo Maligna Melanoma+4 more National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)UnknownNCT03955354What this trial is testingPD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral MelanomaWho this might be right forMelanoma Peking University Cancer Hospital & Institute 30
Testing effectiveness (Phase 2)UnknownNCT05087602What this trial is testingToripalimab Combined With Anlotinib in Unresectable Locally Advanced or Metastatic Acral Malignant MelanomaWho this might be right forLocally Advanced or Metastatic Acral Malignant Melanoma Qilu Hospital of Shandong University 29
Testing effectiveness (Phase 2)Study completedNCT02519322What this trial is testingNeoadjuvant and Adjuvant Checkpoint BlockadeWho this might be right forCutaneous MelanomaMucosal MelanomaOcular Melanoma+8 more M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)Ended earlyNCT01120275What this trial is testingGamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV MelanomaWho this might be right forAcral Lentiginous Malignant MelanomaLentigo Maligna Malignant MelanomaNodular Malignant Melanoma+4 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)UnknownNCT04397770What this trial is testingCamrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral MelanomaWho this might be right forMelanoma Peking University Cancer Hospital & Institute 40
Early research (Phase 1)Study completedNCT00005057What this trial is testingGene Therapy and Ganciclovir in Treating Patients With Stage IV MelanomaWho this might be right forMelanoma (Skin) National Human Genome Research Institute (NHGRI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725What this trial is testingLow Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00424515What this trial is testingImatinib in Patients With Mucosal or Acral/Lentiginous MelanomaWho this might be right forMucosal MelanomaAcral/Lentiginous MelanomaChronically Sun Damaged Melanomas Dana-Farber Cancer Institute 24
Large-scale testing (Phase 3)Looking for participantsNCT05549297What this trial is testingTebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)Who this might be right forAdvanced Melanoma Immunocore Ltd 540
Testing effectiveness (Phase 2)UnknownNCT03454919What this trial is testingEfficacy of Palbociclib in Advanced Acral Melanoma With Cell Cycle Gene AberrationsWho this might be right forMelanoma Peking University Cancer Hospital & Institute 60